Alternatives to time-consuming, error-prone operations promise to reduce vaccine manufacturing costs and improve facility flexibility.
Leonard Mestrandrea
Advertisement
LeonardMestrandrea is principal of Mestrandrea Consulting LLC.
Articles by Leonard Mestrandrea
Advertisement
Latest Updated Articles
Moving to Closed Systems for Aseptic ProcessingNovember 15th 2017
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
3
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
4
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
5